Issue: May 2023
Fact checked byGina Brockenbrough, MA

Read more

April 03, 2023
1 min read
Save

Medtronic, DaVita launch new medical technology company called Mozarc Medical

Issue: May 2023
Fact checked byGina Brockenbrough, MA
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • Mozarc Medical will develop kidney-related technology.
  • Products will include home dialysis technology.

Medtronic and DaVita have launched Mozarc Medical, an independent medical technology company focused on kidney health and improving patient-centered technology solutions, according to the press release.

Doctor using an electronic health record
Among the kidney-related devices that will be designed, Mozarc Medical will focus on developing products for home dialysis treatments to improve the patient experience. Image: Adobe Stock

“Mozarc Medical's focus will be on meaningful and innovative kidney health technologies that improve the overall patient experience and increase access to care globally,” Ven Manda, CEO of Mozarc Medical, said in the release. “At a time when patient preferences are evolving and in-home kidney care is on the rise, Mozarc Medical is uniquely positioned to better serve patients with kidney disease around the world.”

As Healio previously reported, the two companies shared the intent to form Mozarc Medical last year. Now, Medtronic Renal Care Solutions has been absorbed into Mozarc Medical, and Medtronic and DaVita will have equal equity stakes in the company.

Among the kidney-related devices that will be designed, Mozarc Medical will focus on developing products for home dialysis treatments to improve the patient experience.

“The launch of Mozarc Medical holds tremendous promise to improve the lives of patients living with kidney disease as it seeks to revolutionize the approach to home dialysis by improving accessibility, ease of use and clinical performance,” Mahesh Krishnan, MD, MPH, MBA, group vice president of research and development at DaVita, said in the release. “Our investment in this venture is born from our decades-long commitment to advancing kidney care, and our aim is that it will fuel patient-centric solutions that may not have otherwise been possible.”